| Literature DB >> 28428538 |
Gang Huang1,2, Jun-Bo Xu1,2, Ting-Jie Zhang3, Xiao-Li Nie1,2, Qiu Li1,2, Ya Liu1, Yan Lv1, Rui-Lian Wen1, Lei Yang1,2, Bao-Yu Zhao1,2.
Abstract
Cardiovascular epidemiological features among very elderly Chinese are still uncertain. This study aimed to describe the distribution of cardiovascular diseases and sex difference, and investigate potential risk factors for diseases clustering among very elderly Chinese. From May 2013 to May 2015, a total of 1056 very elderly were sampled in this cross-sectional study. Demographic characteristics collection, physical examination and biochemical analysis were performed. Totally, 1038 participants (men: 49.8%) with a median age of 83.0 years (age range: 80.0-100.0 years) were included. In this very elderly group, the prevalences of hypertension, diabetes mellitus, renal dysfunction, hyperuricemia, obesity, visceral obesity, and hypercholesterolaemia were 76.9%, 20.0%, 23.3%, 33.0%, 9.4%, 54.5% and 35.8%, respectively. About 17.5% of very elderly (men vs. women: 15.1% vs 19.8%, p = 0.007) have ≥3 cardiovascular diseases clustering. Logistic analysis found that hyperuricemia (odds ratio 3.850, 95%CI 2.189-6.770) was associated with of cardiovascular diseases clustering among very elderly women. Prevalences of prehypertension, hyperuricemia, visceral obesity and dyslipidaemia are apparent in very elderly women, while diabetes mellitus, renal dysfunction are common in very elderly men. Women are more likely to have ≥3 cardiovascular diseases. Hyperuricemia is associated with cardiovascular diseases clustering among very elderly women.Entities:
Mesh:
Year: 2017 PMID: 28428538 PMCID: PMC5430531 DOI: 10.1038/s41598-017-01042-6
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Demographic characteristics and cardiovascular risk factors.
| All | Men (N = 517) | Women (N = 521) | p value | |
|---|---|---|---|---|
| Age, years | 83.6 ± 3.4 | 83.6 ± 3.3 | 83.5 ± 3.4 | 0.191 |
| 83.0 (81.0, 85.0) | 83.0 (81.0, 85.0) | 83.0 (81.0, 85.0) | ||
| Han Ethnicity n, (%) | 1029(99.1)* | 513(99.2) | 516(99.0) | 1.000 |
| Current Smoker n, (%) | 116(11.2)* | 93(18.0) | 23(4.4) | <0.001 |
| Current Drinking n, (%) | 87(8.4)* | 78(15.1) | 9(1.7) | <0.001 |
| Education | ||||
| Illiterate n, (%) | 249(24.0)* | 60(11.6) | 189(36.3) | <0.001 |
| Primary School n, (%) | 312(30.0)* | 154(29.8) | 158(30.3) | 0.913 |
| Middle/High School n, (%) | 336(32.4)* | 210(40.6) | 126(24.1) | <0.001 |
| College/University n, (%) | 141(13.6)* | 93(18.0) | 48(9.3) | <0.001 |
| Blood pressure | ||||
| SBP mmHg | 146.4 ± 20.6 | 145.0 ± 20.0 | 148.0 ± 21.0 | 0.038 |
| DBP mmHg | 74.1 ± 11.9 | 75.0 ± 11.6 | 73.1 ± 12.1 | 0.006 |
| PP mmHg | 72.5 ± 17.1 | 70.2 ± 16.8 | 75.2 ± 17.1 | <0.001 |
| Heart rate, bpm | 70.0 ± 9.0 | 68.4 ± 9.5 | 71.3 ± 8.3 | 0.003 |
| Height, cm | 154.9 ± 10.1 | 161.9 ± 7.3 | 147.9 ± 7.2 | <0.001 |
| Body weight, kg | 55.7 ± 10.9 | 60.4 ± 10.0 | 50.9 ± 9.6 | <0.001 |
| BMI, kg/m2 | 23.1 ± 3.7 | 23.0 ± 3.5 | 23.2 ± 4.0 | 0.484 |
| WC, cm | 87.5 ± 10.6 | 87.7 ± 10.2 | 87.4 ± 10.9 | 0.684 |
| WHtR | 0.57 ± 0.08 | 0.54 ± 0.07 | 0.59 ± 0.08 | <0.001 |
| FG, mmol/L | 5.53 ± 1.35 | 5.65 ± 1.45 | 5.40 ± 1.22 | 0.004 |
| Lipids | ||||
| TC, mmol/L | 4.87 ± 0.99 | 4.67 ± 0.94 | 5.09 ± 1.00 | <0.001 |
| TG, mmol/L | 1.34 ± 0.57 | 1.30 ± 0.57 | 1.38 ± 0.56 | 0.005 |
| LDL–C, mmol/L | 2.58 ± 0.74 | 2.49 ± 0.72 | 2.69 ± 0.75 | <0.001 |
| HDL–C, mmol/L | 1.60 ± 0.44 | 1.52 ± 0.41 | 1.69 ± 0.46 | <0.001 |
| UA, μmol/L | 350.1 ± 84.5 | 366.9 ± 81.9 | 331.2 ± 85.6 | <0.001 |
| Creatinine, μmol/L | 104.1 ± 32.4 | 111.3 ± 34.2 | 95.8 ± 28.0 | <0.001 |
| e GFR, ml/(min · 1.73 m2) | 58.7 ± 13.9 | 62.1 ± 14.0 | 56.6 ± 12.7 | <0.001 |
BMI, body mass index; DBP, diastolic blood pressure; eGFR, estimated goblet filtration rate; FG, fasting glucose; HDL–C, high–density lipoprotein cholesterol; LDL-C, low–density lipoprotein cholesterol; PP, pulse pressure; SBP, systolic blood pressure; TC, total cholesterol; TG, triglycerides; UA, Uric acid; WC, waist circumference; WHtR, waist–to-height ratio. Data are presented as mean ± standard deviation for continuous variables and as frequencies (percentages) for categorical variables, age also presented as median (interquartile). eGFR was calculated according to Cockcroft-Gault equation. *Prevalences are standardized for age and sex.
Estimated prevalence of cardiovascular abnormalities.
| All *n, % (95%CI) | Men (N = 517) n, % (95%CI) | Women (N = 521) n, % (95%CI) | p value | |
|---|---|---|---|---|
| Pre Hypertension | 173, 16.6(14.4–18.9) | 83, 16.0(12.9–19.2) | 90, 17.2(14.0–20.5) | 0.598 |
| Hypertension | 797, 76.9(74.2–79.4) | 391, 75.6(71.9–79.3) | 406, 78.0(74.4–81.5) | 0.353 |
| Self-reported | 545, 68.4(65.2–71.6) | 261, 66.8(62.1–71.4) | 284, 70.0(65.5–74.4) | 0.332 |
| IFG | 61, 5.8(4.4–7.3) | 37, 7.1(4.9–9.4) | 24, 4.6(2.8–6.4) | 0.130 |
| DM | 209, 20.0(17.6–22.5) | 111, 21.4(17.9–25.0) | 98, 18.8(15.5–22.2) | 0.285 |
| Self-reported | 123, 58.9(52.2–65.5) | 58, 52.3(43.0–61.5) | 65, 66.3(57.0–75.7) | 0.039 |
| Renal dysfunction | 242, 23.3(20.7–25.9) | 169, 32.6(28.6–36.6) | 73, 14.1(11.1–17.1) | <0.001 |
| ** | 574, 55.3(52.3–58.3) | 220, 42.6(38.3–46.8) | 354, 67.9(63.9–72.0) | <0.001 |
| Hyperuricemia | 342, 33.0(30.1–35.8) | 156, 30.2(26.2–34.1) | 185, 35.6(31.4–39.6) | 0.075 |
| Persistant AF | 54, 5.2(3.8–6.5) | 31, 5.9(3.9–7.9) | 23, 4.5(2.7–6.3) | 0.316 |
| Persistant Af | 3, 0.3(0.0–0.6) | 1, 0.2(−0.2–0.6) | 2, 0.4(−0.1–0.9) | 0.604 |
| I AVB | 64, 6.3(4.8–7.8) | 38, 7.4(5.1–9.7) | 27, 5.1(3.2–7.0) | 0.137 |
| II/III AVB | 2, 0.2(−0.1–0.4) | 2, 0.4(−0.1–0.9) | 0 | 0.345 |
| RBBB | 106, 10.2(8.3–12.0) | 55, 10.6(7.9–13.3) | 51, 9.8(7.2–12.4) | 0.663 |
| LBBB | 6, 0.6(0.1–1.0) | 4, 0.8(0.0–1.5) | 2, 0.4(−0.1–0.9) | 0.788 |
| Overweight | 312, 30.0(27.3–32.8) | 156, 30.2(26.2–34.1) | 156, 29.9(26.0–33.9) | 0.920 |
| Obesity | 98, 9.4(7.6–11.1) | 41, 7.9(40.8–49.4) | 57, 10.9(8.1–13.4) | 0.138 |
| Visceral Obesity | 560, 54.5(51.5–57.6) | 233, 45.1(5.6–10.3) | 327, 62.7(58.6–66.9) | <0.001 |
| Hypercholesterolaemia | 367, 35.8(32.9–38.8) | 144, 27.9(24.0–31.7) | 223, 42.8(38.6–47.1) | <0.001 |
| Hypertrigleicemiea | 222, 21.6(18.9–23.9) | 97, 18.8(15.4–22.1) | 125, 24.0(20.3–27.7) | 0.048 |
| Hyper-low density lipoproteinemia | 152, 14.9(12.8–17.1) | 59, 11.4(8.7–14.2) | 93, 17.9(14.6–21.1) | 0.004 |
| Hypo-high density lipoproteinemia | 69, 6.5(5.1–8.2) | 46, 8.9(6.4–11.4) | 23, 4.5(2.7–6.2) | 0.008 |
AF, atrial fibrillation; Af, atrial flutter; AVB, atrial ventricular block; DM, diabetes mellitus; FG, fast glucose; IFG, impaired fasting glucose; LBBB, = left bundle brach block; RBBB, right bundle brach block. Data are presented as and as number, frequency (95% confidence interval). *Prevalences are standardized for age and sex. **Prevalence of renal dysfunction was defined as e GFR < 60 ml/(min · 1.73 m2) according to Cockcroft-Gault equation.
Percentage of comorbid abnormalities.
| Percentage n, % (95%CI) | |||
|---|---|---|---|
| Among Hypertension (N = 797) | Among DM (N = 209) | Among both hypertension and DM (N = 183) | |
| Hypertension | — | 173, 82.8(77.7–87.9) | — |
| DM | 175, 22.0(19.1–24.8) | — | — |
| Renal dysfunction | 194, 24.3(21.4–27.3) | 55, 26.3(20.3–32.3) | 50, 27.3(20.9–33.8) |
| Overweight | 257, 32.2(29.0–35.5) | 73, 34.9(28.5–41.4) | 56, 30.6(23.9–37.3) |
| Obesity | 87, 10.9(8.8–13.1) | 32, 15.3(10.4–20.2) | 19, 10.4(6.0–14.8) |
| Visceral Obesity | 457, 57.3(53.9–60.8) | 132, 63.2(56.6–69.7) | 99, 54.1(46.9–61.3) |
| Hypercholesterolaemia | 292, 36.6(33.3–40.0) | 74, 35.4(28.9–41.9) | 65, 35.5(28.6–42.5) |
| Hypertrigleicemiea | 176, 22.1(19.2–25.0) | 58, 27.8(21.7–33.8) | 39, 21.3(15.4–27.2) |
| Hyperuricemia | 285, 35.8(32.4–39.1) | 80, 38.3(31.7–44.9) | 62, 33.9(27.0–40.7) |
DM, diabetes mellitus. Data are presented as frequencies (percentages) for categorical variables. All p value > 0.05, comparison between groups hypertension and DM.
Logistic regression results of risk factors for ≥3 comorbid abnormalities.
| Total | Men | Women | |
|---|---|---|---|
| Age (years) | |||
| 80–84 | Ref. | Ref. | Ref. |
| 85–89 | 0.743 (0.480–1.151) | 0.872 (0.487–1.561) | 0.569 (0.286–1.130) |
| ≥90 | 0.604 (0.262–1.394) | 0.715 (0.228–2.248) | 0.443 (0.125–1.573) |
| Smoking | |||
| No | Ref. | Ref. | Ref. |
| Yes | 0.955 (0.498–1.830) | 0.962 (0.461–2.008) | 0.651 (0.136–3.115) |
| Drinking | |||
| No | Ref. | Ref. | Ref. |
| Yes | 0.812 (0.394–1.672) | 0.653 (0.296–1.443) | 0.761 (0.082–7.035) |
| Visceral Obesity | |||
| No | Ref. | Ref. | Ref. |
| Yes | 1.179 (0.804–1.730) | 1.284 (0.767–2.150) | 1.404 (0.747–2.639) |
| PP ≥ 60 mmHg | |||
| No | Ref. | Ref. | Ref. |
| Yes | 2.684 (1.464–4.920)* | 3.961 (1.741–9.014)* | 1.910 (0.763–4.777) |
| Hyperuricemia | |||
| No | Ref. | Ref. | Ref. |
| Yes | 2.066 (1.418–3.011)* | 1.268 (0.730–2.205) | 3.850 (2.189–6.770)* |
Ref., reference category. Data are presented as odds ratio (95%CI). CI = confidence interval; Hyperuricemia defined as UA ≥ 416 μmol/L in men, UA ≥ 357 μmol/L in women. Visceral Obesity defined as waist circumference ≥90 cm in men, waist circumference ≥85 cm in women. Comorbid abnormalities included hypertension, diabetes mellitus, renal dysfunction, and dyslipidaemia. *P < 0.05 versus reference category.
Figure 1Receiver-operating characteristic curve (ROC) of UA predicting cardiovascular diseases clustering. ROC analysis yielded an optimal cutoff value of 352.5 μmol/L (p < 0.001) for very elderly women. The area under the ROC curve was 0.677 (95%CI 0.611–0.742).